AZUSA, CA -- (MARKET WIRE) -- April 17, 2007 -- Viral Genetics, Inc. (OTCBB: VRAL) has retained two senior advisors as part of its African advisory team as the Company continues the development of VGV-1, the Company's HIV/AIDS product, in Africa. The two advisors joining the advisory team are Dr. Sam Gulube and Mr. Bada Pharasi.
